Pregnancy-Induced Hypertension is Accompanied by Decreased Number of Circulating Endothelial Cells and Circulating Endothelial Progenitor Cells by unknown
SHORT COMMUNICATION
Pregnancy-Induced Hypertension is Accompanied by Decreased
Number of Circulating Endothelial Cells and Circulating
Endothelial Progenitor Cells
Jerzy Heimrath • Maria Paprocka • Andrzej Czekanski •
Agata Ledwozyw • Aneta Kantor • Danuta Dus
Received: 11 July 2013 / Accepted: 11 December 2013 / Published online: 23 February 2014
 The Author(s) 2014. This article is published with open access at Springerlink.com
Abstract Maternal endothelial dysfunction is one of the
main features of pregnancy-induced hypertension (PIH). It
is generally accepted that circulating endothelial cells
(CECs) and endothelial progenitor cells (EPCs) reflect the
state of the endothelium, its injury and/or repair possibili-
ties. The objective of this study was to determine whether
the CECs and EPCs numbers in the circulation of women
with PIH reflect the presence of this pathology. Peripheral
blood cells of PIH and normotensive pregnant women were
labeled with specific monoclonal antibodies. For CECs
evaluation, samples were labeled with anti-CD31 and anti-
CD45 antibodies; for EPCs with anti-VEGFR2/KDR and
anti-CD34 antibodies. Cells were quantified by flow
cytometry. The levels of both CECs (CD31?, CD45-) and
EPCs (CD34?, VEGFR2/KDR?) in the peripheral blood of
women with PIH were significantly lower compared with
those of control pregnant women with normal blood pres-
sure level. Lowered accessibility of maternal CECs and
EPCs may diminish general regenerative potential of the
patient endothelia, contributing to PIH symptoms and to
the risk of subsequent coronary and arterial disease.
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Introduction
According to current opinion, arterial pregnancy-induced
hypertension (PIH) is caused by insufficient placental flow.
In PIH trofoblast fails to modulate its phenotype, which
results in impaired, shallow invasion of spiral arteries.
Reduced uteroplacental perfusion induces series of
hypoxia/ischemia events, accompanied with the imbalance
between vasodilative and the vasopressive factors, a dys-
function of the renin–angiotensin system as well as
endothelium activation. This activation is not restricted to
placental vessels but affects also other maternal endothelia,
making PIH a multisystemic disease. Preeclampsia is a
pregnancy pathology in which PIH is accompanied by
proteinuria and associated with an increased risk of sub-
sequent coronary and arterial diseases (Blum et al. 2003;
Gilbert et al. 2008; Harskamp and Zeeman 2007; Kauf-
mann et al. 2003; Robb et al. 2007; Zhang et al. 1997).
Dysfunction of vascular endothelium in PIH women is
accompanied by elevated amounts of syncytiotrophoblast
particles and increased levels of several soluble adhesion
molecules, e.g., sVCAM and sICAM, in peripheral blood
(Heimrath et al. 2004). Other studies have shown that
concentration of serum vascular endothelial growth factor
(VEGF), von Willebrand factor and fibronectin was also
elevated. Levels of soluble markers, tumor necrosis factor,
endothelin and angiotensin II, may also be elevated
whereas the vasodilator levels, nitric oxide and prostacy-
clin levels, are usually diminished (Blum et al. 2003;
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Gammill et al. 2007; Gilbert et al. 2008; Hunter et al. 2000;
Kwon et al. 2007).
Circulating endothelial cells (CECs) and endothelial
progenitor cells (EPCs) reflect the state of the endothelium,
its injury and/or repair possibilities (Hunting et al. 2005).
CECs are cells peeled off from the vessel wall during
normal or pathological conditions, such as acute inflam-
mation or mechanical trauma. CECs are usually defined as
cells expressing endothelial cell markers, such as CD146,
CD31 or Willebrand factor, but negative for CD45 (Blann
et al. 2005; Khan et al. 2005; Mancuso et al. 2001;
Monestiroli et al. 2001; Woywodt et al. 2002).
Several studies have demonstrated that EPC may par-
ticipate in the postnatal neoangiogenesis. These cells are
characterized by expression of such markers as CD133,
CD34 and VEGFR2 (VEGF receptor 2, also known as
KDR) (Hristov and Weber 2004; Hunting et al. 2005; Robb
et al. 2007; Timmermans et al. 2009).
The aim of this study was to determine whether the
CECs and EPCs numbers in the PIH patients may reflect
the presence of this pathology.
Materials and Methods
Subjects
The study involved 18 pregnant women, 21–35 years,
with PIH, defined according the criteria of blood pressure
elevation [140/90 mmHg, measured at least twice, 6 h
apart, after 20th week of gestation in a previously nor-
motensive women. Dopegyt (Methyldopa) and
Dihydralzine were applied as a standard antihypertension
treatment. Preeclampsia was diagnosed in six women
(30 %) with PIH, on the basis of the presence of 300 mg
of protein or more in a 24-h urine sample. In the group
studied, ten women (55.5 %) were primigravida and eight
women (44.5 %) were multipara. Seven of them (38.8 %)
had premature labor (before the end of the 37th week of
pregnancy). The control consisted of 21 pregnant women
aged 22–43 years, with normal blood pressure level,
having natural labor in term; and included 10 (47.5 %)
primigravida and 11 (52.5 %) multipara. All women had
monovular pregnancies. Main clinical characteristics of
both patient groups were gathered in a Table 1. Pregnant
women in both groups were carefully selected. There was
no patient with HELLP syndrome (preeclampsia variant,
characterized by hemolysis, elevated liver enzymes and
low platelet count). Patients with overweight, cigarette
smoking, diabetes or hypertension were not included in
the group. The main difference between control and PIH
groups was average delivery time: 40 vs. 37 weeks,
respectively, as in PIH pregnancy usually there is a need
of a delivery before the term because of complications
related to hypertension.
The material examined was venous blood drawn directly
before birth into test tubes with an anticoagulant. The
Bioethics Commission of the Wroclaw Medical University
approved this study and all patients gave informed consent.
Flow Cytometry Analysis of CECs and EPCs Numbers
in Peripheral Blood
To determine CECs number, blood samples of PIH patients
and normotensive pregnant women were labeled with
FITC-conjugated anti-CD31 and PerCP-conjugated anti-
CD45 antibodies (BD Biosciences, USA). To evaluate
EPCs number PerCP-conjugated anti-CD34 (BD Biosci-
ences, USA) and PE-conjugated anti-VEGFR2/KDR
antibodies (R&D Systems, USA) were used. Blood sam-
ples were incubated first with FcR-blocking reagent
(Miltenyi Biotec, Germany) and then with selected anti-
bodies. Isotype matched, labeled immunoglobulins (BD
Biosciences, USA or R&D Systems, USA, respectively)
were used as a control. After incubation Lysing Solution
(Sigma, Germany) was applied to eliminate erythrocytes
and fluorescent CytoCount beads (Dako, Denmark) were
used for cell number evaluation. Minimal numbers of
150,000 cells were collected. Flow cytometry was per-
formed using FACSCalibur cytometer, CellQuest software
(Becton–Dickinson, USA) and appropriate cell gating to
eliminate platelets and dead cells (debris gate). EPCs were
evaluated from lymphocyte gate (Redondo et al. 2008) and
CECs from mononuclear cells gate (Mancuso et al. 2001;
Monestiroli et al. 2001; Redondo et al. 2008). Data were
expressed as a cell count per 1 mL of blood. Cell numbers
obtained by flow analysis for control normotensive group
and PIH patients were compared using Mann–Whitney
Table 1 Characteristics of study groups
Control PIH patients
Number of patients 21 18
Age 28 (±5) 30 (±9)
Blood pressure (mm Hg)
Systolic 122 (±10) 174 (±15)
Diastolic 79 (±12) 110 (±15)
Proteinuria 0/21 6/18
Gestational age at the
blood sampling (week)
40 (±2) 37 (±4)
Natural birth 21/21 2/18
Cesarean section 0/21 16/18
Infantile birth weight (g) 3,433.6 (±400) 2,934.6 (±500)
Rate of primipara 47.5 % 55.5 %
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U test (Statistica 6.0 software). Differences were consid-
ered as statistically significant when p \ 0.05.
Results and Discussion
As the endothelium dysfunction plays a significant causal
role in PIH, we have decided for evaluation, in the same
patients, both EPCs and CECs to receive more complete
insight into the problem. Pregnant women with PIH were
found to have approximately twice lower counts of both
EPCs and CECs as compared to normotensive healthy
controls. An average EPCs number in peripheral blood of
healthy controls was 2.48 9 102 but in PIH patients it
decreased to 1.03 9 102 per 1 mL (p = 0.000001; Fig. 1).
CECs counts were 2.77 9 103 in healthy controls and
1.28 9 103 per 1 mL in PIH patients (p = 0.0034; Fig. 2).
Obtained differences were statistically significant.
The process of neoangiogenesis means in situ prolifer-
ation of local endothelial cells but involves also EPCs
mobilized from bone marrow (Hristov and Weber 2004).
To pass over a lack of specific marker for EPC, two, three
or even more markers have to be applied to discriminate
these from platelets and lymphocytes (Robb et al. 2007;
Timmermans et al. 2009).
Our data confirm a few published data that EPCs level in
PIH women was diminished. Sugawara et al. (2005)
reported decrease in EPCs number and found EPCs cellular
senescence. Kwon et al. (2007) also found decreased
number of EPCs in preeclampsia. Gammill et al. (2007)
have reported that EPCs number increases in healthy
pregnancy but similar increase was not observed in woman
with preeclampsia. Only Matsubara et al. (2006) did not
find significant differences in EPCs levels.
CECs number in healthy people, reported in the litera-
ture, ranges from 0 to 7,900 per 1 mL of blood (Khan et al.
2005; Steurer et al. 2008). Our data concerning CECs differ
from those from other laboratories. We have found lower
counts of CECs in PIH patients, compared to normotensive
controls, while publications by Zheng et al. (1996) and
Grundmann et al. (2008) reported augmented number of
CECs in PIH patients. However, their CECs enumerating
methods were different. Zeng’s group isolated CECs before
their counting under microscope, and Grundmann’s group
separated CECs with anti-CD146 antibody and stained
cells with Ulex lectin, which may result in enumeration of
different cell subpopulations. All ten patients evaluated by
Grundman’s study were patients with preeclampsia. PIH
and preeclampsia patients were presented together in our
study, as we had not found any difference in CECs number
in these groups.
It seems also possible that some of CECs released from
activated endothelium disintegrate and form microparticles
(EMs), small vesicles of endothelial cell membrane, con-
taining cytoplasm. In preeclampsia EMs levels, evaluated
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Fig. 1 The numbers of endothelial progenitor cells (EPCs) in 1 mL
of blood of normotensive pregnant woman and patients with
pregnancy-induced hypertension (PIH) evaluated by flow cytometry.
Significantly decreased cell numbers were observed in PIH patients:
1.03 9 102 when compared with normal pregnant control:
2.48 9 102 per 1 mL (*p = 0.000001)
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Fig. 2 The numbers of circulating endothelial cells (CECs) in 1 mL
of blood of normotensive pregnant woman and patients with
pregnancy-induced hypertension (PIH) evaluated by flow cytometry.
Significantly decreased cell numbers were observed in PIH patients:
1.28 9 103 when compared with normal pregnant control:
2.77 9 103 per 1 mL (*p = 0.0034)
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by flow cytometry as CD62? and CD31? CD45- micro-
particles, were significantly higher than in healthy controls
(Gonzalez-Quintero et al. 2004). In our study microparti-
cles were not specifically labeled nor evaluated but by
gating living cells for CEC and EPC counting, we could
observe augmented debris number in PIH patients (data not
shown). This suggests excessive cell’s damage which may
influence final CECs count.
Because EPCs and CECs levels in the peripheral blood
of women with PIH were found to be significantly lower as
compared with those of normotensive pregnant women we
suggest that this phenomenon often accompanied the
pathology. Patients selected for our study were without
overweight, diabetes or hypertension but decreased number
of EPC and CEC numbers may be associated with other
pathological processes such as insulin resistance, which
was also demonstrated to impair functions of these cells
(Thadhani et al. 2004).
One may assume that lower accessibility of these
maternal cells impairs regenerative capabilities of the
endothelium and may be one of the factors contributing to
the development of pregnancy-induced hypertension. In
addition, general endothelial dysfunction and lowered
number of cells able to restore vascular bed may give, as a
remote effect, augmented risk of cardiovascular diseases,
as it was demonstrated recently (Harskamp and Zeeman
2007).
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